PICOS | Inclusion criteria | Exclusion criteria |
---|---|---|
Population | Patients with cancer treated with biomarker-guided therapies. | Patients with cancer not treated with biomarker-guided therapies. |
Intervention | Companion diagnostics. Biomarker-guided therapies. Precision medicine. Personalized medicine. | No companion diagnostics No predictive biomarkers for targeted therapies. No biomarker-guided therapies. Drugs without assessing companion biomarkers. Universal screening tools. Triage procedures. Severity or progression analyses. |
Comparator | Unrestricted. | No comparative treatment. Surgery. |
Outcome | Biomarker characteristics. Methodological approaches. Modeling inputs. | – |
Study type | Full-text economic evaluations (cost-effectiveness analysis, cost-utility analysis). | Abstract. No economic evaluations. No English. Costing studies. Cost-minimization studies. |